Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment
Gespeichert in:
| Autor*in: |
Moog, Gero [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
2013 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Ubiquitin protease Ubp8 is necessary for - Leo, Manuela ELSEVIER, 2018, official publication of the American Gastroenterological Association, Stanford, Calif |
|---|---|
| Übergeordnetes Werk: |
volume:144 ; year:2013 ; number:5 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0016-5085(13)63649-5 |
|---|
| Katalog-ID: |
ELV011858486 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV011858486 | ||
| 003 | DE-627 | ||
| 005 | 20230623093152.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2013 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1016/S0016-5085(13)63649-5 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013020000024.pica |
| 035 | |a (DE-627)ELV011858486 | ||
| 035 | |a (ELSEVIER)S0016-5085(13)63649-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 084 | |a 35.70 |2 bkl | ||
| 084 | |a 42.12 |2 bkl | ||
| 084 | |a 42.15 |2 bkl | ||
| 100 | 1 | |a Moog, Gero |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment |
| 264 | 1 | |c 2013 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Mauss, Stefan |4 oth | |
| 700 | 1 | |a Hueppe, Dietrich |4 oth | |
| 700 | 1 | |a Spengler, Ulrich |4 oth | |
| 700 | 1 | |a Schott, Eckart |4 oth | |
| 700 | 1 | |a Eisenbach, Christoph |4 oth | |
| 700 | 1 | |a Schober, Andreas |4 oth | |
| 700 | 1 | |a Heyne, Renate |4 oth | |
| 700 | 1 | |a Jung, Maria-Christina |4 oth | |
| 700 | 1 | |a Teuber, Gerlinde |4 oth | |
| 700 | 1 | |a Doss, Margareta Frank |4 oth | |
| 700 | 1 | |a Rössle, Martin |4 oth | |
| 700 | 1 | |a Pape, Stefan |4 oth | |
| 700 | 1 | |a Schuchmann, Marcus |4 oth | |
| 700 | 1 | |a Alshuth, Ulrich |4 oth | |
| 700 | 1 | |a Buggisch, Peter |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n HighWire Press |a Leo, Manuela ELSEVIER |t Ubiquitin protease Ubp8 is necessary for |d 2018 |d official publication of the American Gastroenterological Association |g Stanford, Calif |w (DE-627)ELV000307017 |
| 773 | 1 | 8 | |g volume:144 |g year:2013 |g number:5 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0016-5085(13)63649-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.70 |j Biochemie: Allgemeines |q VZ |
| 936 | b | k | |a 42.12 |j Biophysik |q VZ |
| 936 | b | k | |a 42.15 |j Zellbiologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 144 |j 2013 |e 5 |h 0 |y 144.2013, 5, S-982- | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
g m gm |
|---|---|
| matchkey_str |
mooggeromaussstefanhueppedietrichspengle:2013----:a01oervraetilteaynobntowtpgnefrnlaalsiaiipudrelieodtosnramnnvptetifcewtcrnceaii |
| hierarchy_sort_str |
2013 |
| bklnumber |
35.70 42.12 42.15 |
| publishDate |
2013 |
| allfields |
10.1016/S0016-5085(13)63649-5 doi GBVA2013020000024.pica (DE-627)ELV011858486 (ELSEVIER)S0016-5085(13)63649-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Moog, Gero verfasserin aut Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Mauss, Stefan oth Hueppe, Dietrich oth Spengler, Ulrich oth Schott, Eckart oth Eisenbach, Christoph oth Schober, Andreas oth Heyne, Renate oth Jung, Maria-Christina oth Teuber, Gerlinde oth Doss, Margareta Frank oth Rössle, Martin oth Pape, Stefan oth Schuchmann, Marcus oth Alshuth, Ulrich oth Buggisch, Peter oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:144 year:2013 number:5 pages:0 https://doi.org/10.1016/S0016-5085(13)63649-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 144 2013 5 0 144.2013, 5, S-982- 045F 610 |
| spelling |
10.1016/S0016-5085(13)63649-5 doi GBVA2013020000024.pica (DE-627)ELV011858486 (ELSEVIER)S0016-5085(13)63649-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Moog, Gero verfasserin aut Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Mauss, Stefan oth Hueppe, Dietrich oth Spengler, Ulrich oth Schott, Eckart oth Eisenbach, Christoph oth Schober, Andreas oth Heyne, Renate oth Jung, Maria-Christina oth Teuber, Gerlinde oth Doss, Margareta Frank oth Rössle, Martin oth Pape, Stefan oth Schuchmann, Marcus oth Alshuth, Ulrich oth Buggisch, Peter oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:144 year:2013 number:5 pages:0 https://doi.org/10.1016/S0016-5085(13)63649-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 144 2013 5 0 144.2013, 5, S-982- 045F 610 |
| allfields_unstemmed |
10.1016/S0016-5085(13)63649-5 doi GBVA2013020000024.pica (DE-627)ELV011858486 (ELSEVIER)S0016-5085(13)63649-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Moog, Gero verfasserin aut Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Mauss, Stefan oth Hueppe, Dietrich oth Spengler, Ulrich oth Schott, Eckart oth Eisenbach, Christoph oth Schober, Andreas oth Heyne, Renate oth Jung, Maria-Christina oth Teuber, Gerlinde oth Doss, Margareta Frank oth Rössle, Martin oth Pape, Stefan oth Schuchmann, Marcus oth Alshuth, Ulrich oth Buggisch, Peter oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:144 year:2013 number:5 pages:0 https://doi.org/10.1016/S0016-5085(13)63649-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 144 2013 5 0 144.2013, 5, S-982- 045F 610 |
| allfieldsGer |
10.1016/S0016-5085(13)63649-5 doi GBVA2013020000024.pica (DE-627)ELV011858486 (ELSEVIER)S0016-5085(13)63649-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Moog, Gero verfasserin aut Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Mauss, Stefan oth Hueppe, Dietrich oth Spengler, Ulrich oth Schott, Eckart oth Eisenbach, Christoph oth Schober, Andreas oth Heyne, Renate oth Jung, Maria-Christina oth Teuber, Gerlinde oth Doss, Margareta Frank oth Rössle, Martin oth Pape, Stefan oth Schuchmann, Marcus oth Alshuth, Ulrich oth Buggisch, Peter oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:144 year:2013 number:5 pages:0 https://doi.org/10.1016/S0016-5085(13)63649-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 144 2013 5 0 144.2013, 5, S-982- 045F 610 |
| allfieldsSound |
10.1016/S0016-5085(13)63649-5 doi GBVA2013020000024.pica (DE-627)ELV011858486 (ELSEVIER)S0016-5085(13)63649-5 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Moog, Gero verfasserin aut Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Mauss, Stefan oth Hueppe, Dietrich oth Spengler, Ulrich oth Schott, Eckart oth Eisenbach, Christoph oth Schober, Andreas oth Heyne, Renate oth Jung, Maria-Christina oth Teuber, Gerlinde oth Doss, Margareta Frank oth Rössle, Martin oth Pape, Stefan oth Schuchmann, Marcus oth Alshuth, Ulrich oth Buggisch, Peter oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:144 year:2013 number:5 pages:0 https://doi.org/10.1016/S0016-5085(13)63649-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 144 2013 5 0 144.2013, 5, S-982- 045F 610 |
| source |
Enthalten in Ubiquitin protease Ubp8 is necessary for Stanford, Calif volume:144 year:2013 number:5 pages:0 |
| sourceStr |
Enthalten in Ubiquitin protease Ubp8 is necessary for Stanford, Calif volume:144 year:2013 number:5 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Biochemie: Allgemeines Biophysik Zellbiologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Ubiquitin protease Ubp8 is necessary for |
| authorswithroles_txt_mv |
Moog, Gero @@aut@@ Mauss, Stefan @@oth@@ Hueppe, Dietrich @@oth@@ Spengler, Ulrich @@oth@@ Schott, Eckart @@oth@@ Eisenbach, Christoph @@oth@@ Schober, Andreas @@oth@@ Heyne, Renate @@oth@@ Jung, Maria-Christina @@oth@@ Teuber, Gerlinde @@oth@@ Doss, Margareta Frank @@oth@@ Rössle, Martin @@oth@@ Pape, Stefan @@oth@@ Schuchmann, Marcus @@oth@@ Alshuth, Ulrich @@oth@@ Buggisch, Peter @@oth@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000307017 |
| dewey-sort |
3610 |
| id |
ELV011858486 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV011858486</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623093152.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0016-5085(13)63649-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013020000024.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV011858486</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5085(13)63649-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Moog, Gero</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mauss, Stefan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hueppe, Dietrich</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Spengler, Ulrich</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schott, Eckart</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eisenbach, Christoph</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schober, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heyne, Renate</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jung, Maria-Christina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teuber, Gerlinde</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Doss, Margareta Frank</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rössle, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pape, Stefan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schuchmann, Marcus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alshuth, Ulrich</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buggisch, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">HighWire Press</subfield><subfield code="a">Leo, Manuela ELSEVIER</subfield><subfield code="t">Ubiquitin protease Ubp8 is necessary for</subfield><subfield code="d">2018</subfield><subfield code="d">official publication of the American Gastroenterological Association</subfield><subfield code="g">Stanford, Calif</subfield><subfield code="w">(DE-627)ELV000307017</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:144</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0016-5085(13)63649-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">144</subfield><subfield code="j">2013</subfield><subfield code="e">5</subfield><subfield code="h">0</subfield><subfield code="y">144.2013, 5, S-982-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Moog, Gero |
| spellingShingle |
Moog, Gero ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment |
| authorStr |
Moog, Gero |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000307017 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment |
| topic |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
| topic_unstemmed |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
| topic_browse |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s m sm d h dh u s us e s es c e ce a s as r h rh m c j mcj g t gt m f d mf mfd m r mr s p sp m s ms u a ua p b pb |
| hierarchy_parent_title |
Ubiquitin protease Ubp8 is necessary for |
| hierarchy_parent_id |
ELV000307017 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
| hierarchy_top_title |
Ubiquitin protease Ubp8 is necessary for |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000307017 |
| title |
Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment |
| ctrlnum |
(DE-627)ELV011858486 (ELSEVIER)S0016-5085(13)63649-5 |
| title_full |
Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment |
| author_sort |
Moog, Gero |
| journal |
Ubiquitin protease Ubp8 is necessary for |
| journalStr |
Ubiquitin protease Ubp8 is necessary for |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Moog, Gero |
| container_volume |
144 |
| class |
610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Moog, Gero |
| doi_str_mv |
10.1016/S0016-5085(13)63649-5 |
| dewey-full |
610 570 |
| title_sort |
sa1051 boceprevir based triple therapy in combination with peginterferon-alfa-2a plus ribavirin (p/r) under real life conditions in treatment naïve patients infected with chronic hepatitis c, genotype 1: an interim analysis at week 12 after start of treatment |
| title_auth |
Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
5 |
| title_short |
Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment |
| url |
https://doi.org/10.1016/S0016-5085(13)63649-5 |
| remote_bool |
true |
| author2 |
Mauss, Stefan Hueppe, Dietrich Spengler, Ulrich Schott, Eckart Eisenbach, Christoph Schober, Andreas Heyne, Renate Jung, Maria-Christina Teuber, Gerlinde Doss, Margareta Frank Rössle, Martin Pape, Stefan Schuchmann, Marcus Alshuth, Ulrich Buggisch, Peter |
| author2Str |
Mauss, Stefan Hueppe, Dietrich Spengler, Ulrich Schott, Eckart Eisenbach, Christoph Schober, Andreas Heyne, Renate Jung, Maria-Christina Teuber, Gerlinde Doss, Margareta Frank Rössle, Martin Pape, Stefan Schuchmann, Marcus Alshuth, Ulrich Buggisch, Peter |
| ppnlink |
ELV000307017 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/S0016-5085(13)63649-5 |
| up_date |
2024-07-06T20:58:46.906Z |
| _version_ |
1803864796726034432 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV011858486</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623093152.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0016-5085(13)63649-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013020000024.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV011858486</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5085(13)63649-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Moog, Gero</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mauss, Stefan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hueppe, Dietrich</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Spengler, Ulrich</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schott, Eckart</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eisenbach, Christoph</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schober, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heyne, Renate</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jung, Maria-Christina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teuber, Gerlinde</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Doss, Margareta Frank</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rössle, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pape, Stefan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schuchmann, Marcus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alshuth, Ulrich</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buggisch, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">HighWire Press</subfield><subfield code="a">Leo, Manuela ELSEVIER</subfield><subfield code="t">Ubiquitin protease Ubp8 is necessary for</subfield><subfield code="d">2018</subfield><subfield code="d">official publication of the American Gastroenterological Association</subfield><subfield code="g">Stanford, Calif</subfield><subfield code="w">(DE-627)ELV000307017</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:144</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0016-5085(13)63649-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">144</subfield><subfield code="j">2013</subfield><subfield code="e">5</subfield><subfield code="h">0</subfield><subfield code="y">144.2013, 5, S-982-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400483 |